TABLE 6.
Frequency of CMV antigenemia among patients who tested positive for CMV antibody
| Category | Non-SCT and auto-SCT patients
|
Allo-SCT patientsb
|
||
|---|---|---|---|---|
| No. of CMV antigenemia-positive patients/no. of antibody-positive patients (%) | RRa (P value) | No. of CMV antigenemia-positive patients/no. of antibody-positive patients (%) | RR (P value) | |
| Ethnicity | ||||
| White | 92/770 (11.9) | 1.0 | 313/621 (50.4) | 1.0 |
| Black | 23/129 (17.8) | 1.49 (0.064) | 25/41 (61.0) | 1.21 (NSc) |
| Asian | 13/54 (24.1) | 2.01 (0.010) | 40/54 (74.1) | 1.47 (<0.001) |
| Hispanic | 35/188 (18.6) | 1.56 (0.016) | 77/146 (52.7) | 1.05 (NS) |
| Sex | ||||
| Male | 99/600 (16.5) | 0.72d (0.024) | 245/494 (49.6) | 1.15d (0.028) |
| Female | 64/541 (11.8) | 210/368 (57.1) | ||
| Total | 163/1,141 (14.3) | 455/862 (52.8) | ||
a
RR, relative risk.
b
Number of virus-positive patients after allo-SCT/number of antibody-positive patients before allo-SCT.
c
NS, not significant.
d
Female versus male.